Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 2/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 3/20 | 0.31 |
| ▸ | JAK2 | O60674 | 2/20 | 0.31 |
| ▸ | BTK | Q06187 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19038789 | 0.85 | P2RX4 (0.34) | LPLLIPGJAK2BTK | |
| SCHEMBL19037731 | 0.85 | LPL (0.33) | LPLLIPGCYP1A2CYP2D6KMT2A | |
| SCHEMBL19038798 | 0.83 | HDAC6 (0.37) | LPLLIPGCYP1A2KMT2AJAK2 | |
| SCHEMBL19038802 | 0.82 | LPL (0.34) | LPLLIPGJAK2BTK | |
| SCHEMBL17739624 | 0.80 | LIPG (0.50) | LPLLIPGCYP1A2CYP2D6KMT2A | |
| SCHEMBL31261579 | 0.80 | LIPG (0.50) | LPLLIPGCYP1A2CYP2D6KMT2A | |
| SCHEMBL18267531 | 0.80 | LPL (0.38) | LPLLIPGCYP1A2CYP2D6KMT2A | |
| SCHEMBL17923618 | 0.80 | LIPG (0.41) | LPLLIPGCYP1A2CYP2D6KMT2A | |
| SCHEMBL21510251 | 0.79 | LPL (0.40) | LPLLIPG | |
| SCHEMBL23730307 | 0.78 | PGR (0.33) | CYP1A2CYP2D6KMT2APGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10700287-B2 | Organic electroluminescent compound and organic photoelectric apparatus | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2020-06-30 | — | — | US | disclosed |
| US-20170186962-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC PHOTOELECTRIC APPARATUS | Shanghai Tianma AM-OLED Co., Ltd. | 2017-06-29 | — | — | US | disclosed |
| US-20170186962-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC PHOTOELECTRIC APPARATUS | Shanghai Tianma AM-OLED Co., Ltd. | 2017-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170186962-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC PHOTOELECTRIC APPARATUS | H1-10, OR10J3, H1-0 | LPL 3215/4885LIPG 3440/4885CYP1A2 1000/4885 |
| US-10700287-B2 | Organic electroluminescent compound and organic photoelectric apparatus | H1-10, OR10J3, H1-0 | LPL 3215/4885LIPG 3440/4885CYP1A2 1000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.